Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aflibercept-mediated early angiogenic changes in aggressive B-cell lymphoma.
Romero M, Brière J, de Bazelaire C, Lebœuf C, Wang L, Ratajczak P, Sibon D, de Kerviler E, Thieblemont C, Janin A. Romero M, et al. Among authors: de bazelaire c, de kerviler e. Cancer Chemother Pharmacol. 2011 Nov;68(5):1135-43. doi: 10.1007/s00280-011-1589-9. Epub 2011 Mar 5. Cancer Chemother Pharmacol. 2011. PMID: 21380563
Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients.
Sibon D, Ertault M, Al Nawakil C, de Bazelaire C, Franchi P, Brière J, de Kerviler E, Beranger N, Thieblemont C, Brice P. Sibon D, et al. Among authors: de bazelaire c, de kerviler e. Br J Haematol. 2011 Apr;153(2):191-8. doi: 10.1111/j.1365-2141.2011.08594.x. Epub 2011 Mar 8. Br J Haematol. 2011. PMID: 21385169 Free article. Clinical Trial.
Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.
de Bazelaire C, Calmon R, Thomassin I, Brunon C, Hamy AS, Fournier L, Balvay D, Espié M, Siauve N, Clément O, de Kerviler E, Cuénod CA. de Bazelaire C, et al. Among authors: de kerviler e. BMC Cancer. 2011 Aug 19;11:361. doi: 10.1186/1471-2407-11-361. BMC Cancer. 2011. PMID: 21854572 Free PMC article.
Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.
Giacchetti S, Faucheux L, Gardair C, Cuvier C, de Roquancourt A, Campedel L, Groheux D, de Bazelaire C, Lehmann-Che J, Miquel C, Cahen Doidy L, Amellou M, Madelaine I, Reyal F, Someil L, Hocini H, Hennequin C, Teixeira L, Espié M, Chevret S, Soumelis V, Hamy AS. Giacchetti S, et al. Among authors: de bazelaire c. Cancers (Basel). 2022 Mar 4;14(5):1331. doi: 10.3390/cancers14051331. Cancers (Basel). 2022. PMID: 35267639 Free PMC article.
[CT and MRI imaging in tumoral angiogenesis].
de Bazelaire C, Calmon R, Chapellier M, Pluvinage A, Frija J, de Kerviler E. de Bazelaire C, et al. Among authors: de kerviler e. Bull Cancer. 2010 Jan;97(1):79-90. doi: 10.1684/bdc.2010.0961. Bull Cancer. 2010. PMID: 19858045 French.
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.
Lehmann-Che J, Amira-Bouhidel F, Turpin E, Antoine M, Soliman H, Legres L, Bocquet C, Bernoud R, Flandre E, Varna M, de Roquancourt A, Plassa LF, Giacchetti S, Espié M, de Bazelaire C, Cahen-Doidy L, Bourstyn E, Janin A, de Thé H, Bertheau P. Lehmann-Che J, et al. Among authors: de bazelaire c, de the h, de roquancourt a. Br J Cancer. 2011 May 24;104(11):1739-46. doi: 10.1038/bjc.2011.135. Epub 2011 May 3. Br J Cancer. 2011. PMID: 21540864 Free PMC article.
74 results